AAAAAA

   
Results: 1-25 | 26-32 |
Results: 26-32/32
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia
Authors: Loprinzi, CL Kugler, JW Sloan, JA Mailliard, JA Krook, JE Wilwerding, MB Rowland, KM Camoriano, JK Novotny, PJ Christensen, BJ
Citation: Cl. Loprinzi et al., Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia, J CL ONCOL, 17(10), 1999, pp. 3299-3306
Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy
Authors: Galanis, E Frytak, S Rowland, KM Sloan, JA Lennon, VA
Citation: E. Galanis et al., Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy, CANCER IMMU, 48(2-3), 1999, pp. 85-90
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy
Authors: Okuno, SH Woodhouse, CO Loprinzi, CL Sloan, JA LaVasseur, BI Clemens-Schutjer, D Swan, D Axvig, C Ebbert, LP Tirona, MRBT Michalak, JC Pierson, N
Citation: Sh. Okuno et al., Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy, AM J CL ONC, 22(3), 1999, pp. 258-261
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer
Authors: Marschke, RF Grill, JP Sloan, JA Wender, DB Levitt, R Mailliard, JA Gerstner, JB Ghosh, C Morton, RF Jett, JR
Citation: Rf. Marschke et al., Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer, AM J CL ONC, 22(1), 1999, pp. 15-17
Sample size and design considerations for phase II clinical trials with correlated observations
Authors: Sargent, DJ Sloan, JA Cha, SS
Citation: Dj. Sargent et al., Sample size and design considerations for phase II clinical trials with correlated observations, CONTR CL TR, 20(3), 1999, pp. 242-252
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer
Authors: Loprinzi, CL Kugler, JW Sloan, JA Rooke, TW Quella, SK Novotny, P Mowat, RB Michalek, JC Stella, PJ Levitt, R Tschetter, LK Windschitl, H
Citation: Cl. Loprinzi et al., Lack of effect of coumarin in women with lymphedema after treatment for breast cancer, N ENG J MED, 340(5), 1999, pp. 346-350
Cerebral toxicity in patients treated for small cell carcinoma of the lung
Authors: Fonseca, R O'Neill, BP Foote, RL Grill, JP Sloan, JA Frytak, S
Citation: R. Fonseca et al., Cerebral toxicity in patients treated for small cell carcinoma of the lung, MAYO CLIN P, 74(5), 1999, pp. 461-465
Risultati: 1-25 | 26-32 |